Lataa...
Cancer-Preventive Rexinoid Modulates Neutral Lipid Contents of Mammary Epithelial Cells through a Peroxisome Proliferator-Activated Receptor γ-Dependent Mechanism
Synthetic rexinoids effectively suppress both estrogen receptor-positive and estrogen receptor-negative mammary tumors in animal models, which makes them prime candidates for a novel class of cancer-preventive agents. When used in combination with chemotherapy for non–small-cell lung cancer, the rex...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The American Society for Pharmacology and Experimental Therapeutics
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3263950/ https://ncbi.nlm.nih.gov/pubmed/22053058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.111.072967 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|